Angela Anagnos, MD
Sleep Medicine · San Jose, CANPI 1174542047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.8% of the total across 163 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Harmony Biosciences LLC at 31.4% of the total.
Across 163 payments — averaging $41.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$2K
- Jazz Pharmaceuticals Inc.$1K
- Novartis$513
- AstraZeneca$365
- Inspire Medical Systems, Inc.$334
- Akcea Therapeutics, Inc.$317
- plus $2K from 21 others
What the payments were for
- Consulting fees$1502%
- Food & beverage$6,08091%
- Education$4637%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 57 | $2,101 |
| Jazz Pharmaceuticals Inc. | 36 | $1,067 |
| Novartis | 6 | $513 |
| AstraZeneca(2 entities) | 3 | $365 |
| Inspire Medical Systems, Inc. | 9 | $334 |
| Akcea Therapeutics, Inc. | 5 | $317 |
| Axsome Therapeutics, Inc. | 10 | $308 |
| Avadel CNS Pharmaceuticals, LLC | 8 | $227 |
| Adamas Pharmaceuticals, Inc. | 3 | $176 |
| AbbVie | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| UCB, Inc. | 1 | $112 |
| Boston Scientific | 1 | $110 |
| Terumo Medical Corporation | 1 | $104 |
| Noctrix Health, Inc. | 1 | $102 |
| Resmed Corp | 5 | $102 |
| Biohaven Pharmaceuticals, Inc. | 1 | $98 |
| Medtronic | 1 | $91 |
| Arbor Pharmaceuticals, Inc. | 3 | $62 |
| Scilex Pharmaceuticals Inc. | 1 | $61 |
| Alnylam Pharmaceuticals Inc. | 2 | $45 |
| Sanofi | 2 | $38 |
| Itamar Medical Inc | 1 | $34 |
| Lilly USA, LLC | 1 | $26 |
| Philips North America LLC | 1 | $20 |
| Emergent Biosolutions Inc. | 1 | $15 |
| 3b Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,694 in reported general payments places this provider in the 80th percentile of 200 sleep medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Oxybate | 12 | $152,853 |
| Modafinil | 14 | $805 |
| Gabapentin | 18 | $148 |
| Zolpidem Tartrate | 12 | $74 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 11 | $19 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in San Jose
- Lisa ShivesSan Diego$1.4M
- Haramandeep SinghSan Ramon$1.1M
- Atul MalhotraSan Diego$771K
- Logan SchneiderStanford$506K
- Tony MasriLos Gatos$327K
- Sam KashaniSanta Monica$221K
- Emmanuel MignotStanford$135K
- Jerome HesterPalo Alto$74K
- Mark BuchfuhrerDowney$70K
- Clete KushidaStanford$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.